Skip to main content
SpringerLink
Log in

Primary central nervous system lymphoma: Variety of clinical manifestations and survival

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

A retrospective analysis of 23 non-immune compromised patients with primary central nervous system lymphoma (PCNSL) is reported. The patients consist of 14 males and 9 females and the median age is 50 years. Most patients presented with focal neurological deficits or symptoms of increased intracranial pressure (ICP) due to mass effects around the periventricular area. However, there were four cases of diffuse type, one case of intramedullary tumour, and four cases with rapid disease progression. All the patients underwent histological confirmation by craniotomy (16 cases) or stereotactic biopsy (7 cases). The radiation therapy started after histological diagnosis in all and 6 cases received additional chemotherapy.

The median survival after diagnosis of overall patients was 23 months. Six patients are in disease free status at a mean of 35 months follow-up. The uni- and multi-variative risk analysis revealed five favourable factors on survival: (1) age less than 60 years (0.05 < p < 0.1); (2) pre-operative Karnof-sky performance scale (KPS) ≥ 70 (p < 0.05); (3) symptom duration over four weeks (p < 0.05); (4) radiation dosage ≥ 5500 cGy (p < 0.05); (5) absence of malignant cells in cerebrospinal fluid (CSF) (p < 0.05). The most frequent site of recurrence was the local area as shown in seven cases out of 11 recurrent cases. But six patients had diffuse recurrence (4 cases), systemic recurrence (2 cases), and drop metastasis (1 case). Although the recurred PCNSL had rapid progression and a grave prognosis, aggressive treatment prolonged the postrecurrence survival time significantly. Our experience suggests that 1) there are various clinical and radiological presentations and progressions of the disease; 2) treatment method should be decided along with the clinical presentation, progression of disease, and prognostic factors; 3) early diagnosis and early detection of recurrence enable the start of definitive treatment when the medical condition is still satisfactory.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aho R, Ekfors T, Haltia M, Kalimo H (1993) Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme. Acta Neuropathol (Berl) 86: 71–76

    Google Scholar 

  2. Ashby MA, Bowen D, Bleehen NM, Barner PC, Freer CEL (1988) Primary lymphoma of the central nervous system: experience at Addenbrooke's hospital, Cambridge. Clin Radiol 39: 173–181

    PubMed  Google Scholar 

  3. Berry MP, Simpson WJ (1981) Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 7: 55–59

    PubMed  Google Scholar 

  4. Bogdahn U, Bogdahn S, Mertens HG, Dommasch D, Woedarz R, Wuensch PH, Kuehl P, Richter E (1986) Primary non-Hodgkin's lymphomas of the CNS. Acta Neurol Scand 73: 602–614

    PubMed  Google Scholar 

  5. Brada M, Dearnaley D, Horwich A, Bloom HJG (1990) Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 18: 787–792

    PubMed  Google Scholar 

  6. Chamberlain MC, Levin VA (1992) Primary central nervous system lymphoma: a role for adjuvant chemotherapy. J Neurooncol 14(3): 271–275

    PubMed  Google Scholar 

  7. Crossen JR, Goldman DL, Dahlborg SA, Neuwelt EA (1992) Neuropsychological assessment outcomes of nonacquired immunodeficiency syndrome patients with primary central nervous system lymphoma before and after blood-brain barrier disruption chemotherapy. Neurosurgery 30: 23–29

    PubMed  Google Scholar 

  8. DeAngelis LM (1990) Primary central nervous system lymphoma imitates multiple sclerosis. J Neurooncol 9: 177–191

    PubMed  Google Scholar 

  9. DeAngelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G (1990) Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology 40: 80–86

    PubMed  Google Scholar 

  10. DeAngelis LM, Yahalom J, Thaler HT, Kher U (1992) Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635–643

    PubMed  Google Scholar 

  11. Eby NL, Grufferman S, Flannelly CM, Schol SC, Vogel FS, Burger PC (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461–2465

    PubMed  Google Scholar 

  12. Filla A, De-Michele G, D'Armiento FP, Di-Salle F, Cirillo S, Marano E, Chiacchio L, Rapuano A, Buscaino GA (1989) Steroid-induced disappearance of primary central nervous system lymphoma. Clinical, neuroradiological and pathological findings. Acta Neurol (Napoli) 11: 400–407

    Google Scholar 

  13. Freeman CR, Shustik C, Brisson ML, Meagher-Villemure K, Dylewski I (1986) Primary malignant lymphoma of the central nervous system. Cancer 58: 1106–1111

    PubMed  Google Scholar 

  14. Gabbai AA, Hochberg FH, Linggood RM, Bashir R, Hotleman K (1989) High-dose methotrexate for non-AIDS primary central nervous system lymphoma. Report of 13 cases. J Neurosurg 70: 190–194

    PubMed  Google Scholar 

  15. Glass J, Gruber ML, Cher L, Hochberg FH (1994) Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 81: 188–195

    PubMed  Google Scholar 

  16. Gonzalez DG, Schuster-Uitterhoeve LJ (1983) Primary nonHodgkin's lymphoma of the central nervous system. Cancer 51: 2048–2052

    PubMed  Google Scholar 

  17. Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68: 835–853

    PubMed  Google Scholar 

  18. Henry JM, Heffner RR, Dillard SH, Earle KM, Davis RL (1974) Primary malignant lymphomas of the central nervous system. Cancer 34: 1293–1302

    PubMed  Google Scholar 

  19. Kazahaya Y, Doi A, Hamaya K (1992) An autopsy case of primary central nervous system lymphoma with diffuse intracerebral lesion. No To Shinkei 44: 65–70

    PubMed  Google Scholar 

  20. Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A (1985) Primary central nervous system lymphoma. J Neurosurg 62: 522–527

    PubMed  Google Scholar 

  21. Letendre L, Banks PM, Reese DF, Miller RH, Scanion PW, Kiely JM (1982) Primary lymphoma of the central nervous system. Cancer 49: 939–943

    PubMed  Google Scholar 

  22. Littman P, Wang CC (1975) Reticulum cell sarcoma of the brain. Cancer 35: 1412–1420

    PubMed  Google Scholar 

  23. Loeffler JS, Ervin TJ, Mouch P, Skarin A, Weinstein HG (1985) Primary lymphoma of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490–494

    PubMed  Google Scholar 

  24. Mendenhall NP, Thar TL, Agee OF, Harty-Golder B, Ballinger WE Jr, Million RR (1983) Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results for 12 cases. Cancer 52: 1993–2000

    PubMed  Google Scholar 

  25. Michalski JM, Garcia DM, Kase E, Grigsby PW, Simpson JR (1990) Primary central nervous system lymphoma: analysis of prognostic variables and patterns of treatment failure. Radiology 176: 855–860

    PubMed  Google Scholar 

  26. Murray K, Kun L, Cox J (1986) Primary malignant lymphoma of central nervous system: results of treatment of 11 cases and review of the literature. J Neurosurg 65: 600–607

    PubMed  Google Scholar 

  27. Nelson DF, Marth KL, Bonner H, Nelson JS, Newall J, Kerman HD, Thomson JW, Murray KG (1992) Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 23: 9–17

    PubMed  Google Scholar 

  28. Neuwelt EA, Balaban E, Diehl J, Hill S, Frenkel E (1983) Successful treatment of primary central nervous system lymphomas with chemotherapy after osmotic blood-brain barrier opening. Neurosurgery 12: 662–671

    PubMed  Google Scholar 

  29. Neuwelt EW, Frenkel EP, Gumerlock MK, Braziel R, Dana B, Hill SA (1986) Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series. Cancer 58: 1609–1620

    PubMed  Google Scholar 

  30. Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B (1991) Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 19: 1580–1590

    Google Scholar 

  31. Pittman KB, Olweny CL, North JB, Blumbergs PC (1991) Primary central nervous system lymphoma. A report of 9 cases and review of the literature. Oncology 48 (3): 184–187

    PubMed  Google Scholar 

  32. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL (1989) Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939–947

    PubMed  Google Scholar 

  33. Shibamoto Y, Tsutsui K, Dodo Y, Yamabe H, Shima N, Abe M (1990) Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic Vincristine-Doxorubicin-Cyclophosphamide-Prednisolone. Cancer 65: 1907–1912

    PubMed  Google Scholar 

  34. van den Bent MF, Vanneste JA, Ansink BJ (1992) Prolonged remission of primary central nervous system lymphoma after discontinuation of steroid therapy. J Neurooncol 13: 257–259

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea

    D. G. Kim, D. H. Nam, H. W. Jung, K. S. Choi & D. H. Han

Authors
  1. D. G. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. H. Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. W. Jung
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. S. Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. H. Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, D.G., Nam, D.H., Jung, H.W. et al. Primary central nervous system lymphoma: Variety of clinical manifestations and survival. Acta neurochir 138, 280–289 (1996). https://doi.org/10.1007/BF01411738

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01411738

Keywords

Search

Navigation